Biden: By 2030, 50% Of All Vehicles Will Be Electric. Sparking New "Lithium Gold Rush."
Experts predict that the global lithium market will balloon by 500%. That's wonderful news for investors, because a "sure-thing" like this appears once in a lifetime. And this small-cap company just snagged what could be one of the world's largest lithium deposits.
Discover This Company's MASSIVE Lithium Opportunit

ISPC Insider Trading (iSpecimen)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $41,840.00
Insider Selling (Last 12 Months): $0.00

iSpecimen Insider Trading History Chart

This chart shows the insider buying and selling history at iSpecimen by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

iSpecimen Share Price & Price History

Current Price: $22.85
Price Change: Price Increase of +5.34 (30.50%)
As of 11/29/2021 02:34 PM ET

This chart shows the closing price history over time for ISPC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
All Electric Commitment From GM, Volkswagen, Could Put Lithium Stock In A Supercycle
More automakers are pledging to go "fully electric" by 2035. NOW is the perfect time to get in on the "EV Revolution." And the best way to potentially do that, is to skip over the overvalued electric vehicle stocks...
Look At This Under-The-Radar Lithium Company

iSpecimen Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/16/2021Tracy CurleyCFOBuy8,000$5.23$41,840.00View SEC Filing Icon  
See Full Table
Insider Selling at iSpecimen?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for iSpecimen and related companies.

SEC Filings (Institutional Ownership Changes) for iSpecimen (NASDAQ:ISPC)

16.22% of iSpecimen stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ISPC by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

iSpecimen Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2021Millennium Management LLC27,677$0.16M0.0%N/A0.396%Search for SEC Filing on Google Icon
11/16/2021Bleichroeder LP618,180$3.61M0.6%+3.0%8.835%Search for SEC Filing on Google Icon
11/16/2021Citadel Advisors LLC12,755$74K0.0%N/A0.182%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.6,007$35K0.0%N/A0.086%Search for SEC Filing on Google Icon
10/27/2021Telemus Capital LLC24,400$0.14M0.0%N/A0.352%Search for SEC Filing on Google Icon
8/17/2021Bleichroeder LP600,291$4.33M0.7%N/A8.671%Search for SEC Filing on Google Icon
8/12/2021Kepos Capital LP225,000$1.63M0.1%N/A3.466%Search for SEC Filing on Google Icon
8/11/2021Susquehanna International Group LLP11,842$85K0.0%N/A0.182%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
iSpecimen logo
iSpecimen, Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables researchers to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.
Read More on iSpecimen

Today's Range

Now: $22.85
Low: $12.97
High: $28.97

50 Day Range

MA: $6.59
Low: $4.80
High: $17.51

52 Week Range

Now: $22.85
Low: $4.75
High: $24.67

Volume

714,202 shs

Average Volume

2,196,346 shs

Market Capitalization

$159.88 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of iSpecimen?

iSpecimen's top insider shareholders include:
  1. Tracy Curley (CFO)

Who are the major institutional investors of iSpecimen?

iSpecimen's top institutional investors include:
  1. Bleichroeder LP — 8.83%
  2. Millennium Management LLC — 0.40%
  3. Telemus Capital LLC — 0.35%
  4. Citadel Advisors LLC — 0.18%
  5. BlackRock Inc. — 0.09%

Which institutional investors are buying iSpecimen stock?

During the last quarter, ISPC stock was bought by institutional investors including:
  1. Millennium Management LLC
  2. Telemus Capital LLC
  3. Bleichroeder LP
  4. Citadel Advisors LLC
  5. BlackRock Inc.
How This Rare Metal Is Going To Solve A $173 TRILLION World Problem… And Could Benefit Investors
According to Bloomberg NEF, changing the world to "All Green Energy" could cost about $173 trillion. And without this rare metal, going green would be IMPOSSIBLE. That's why there's a literal "gold rush" to find it. (HINT: It's not electric vehicles, nuclear power, or wind energy).
Show Me How This Industry Could Explode!